Hormone therapy reduces inflammation biomarkers for women in early menopause
A 1 mg dose of estradiol reduced biomarkers of inflammation tied to atherosclerosis in postmenopausal women — particularly those in early menopause — participating in the Early vs. Late Intervention Trial with Estradiol.
“Daily intake of hormone therapy reduced generalized inflammation indicated by reduction of multiple biomarkers of inflammation in women within 6 years of menopause,” Roksana Karim, PhD, MBBS, associate professor of clinical preventive medicine at the University of Southern California, told Healio. “Anti-inflammatory effect of HT could be a potential mechanism of anti-atherosclerotic benefit from HT in healthy postmenopausal women within 6 years of menopause.”
Read more from Helio, by Michael Monostra, about HT reduces inflammation biomarkers for women in early menopause
Image Point Fr/Shutterstock.com